New use I

Details for Australian Patent Application No. 2004249099 (hide)

Owner Biovitrum AB

Inventors Nilsson, Cecilia; Dreifeldt, Catrine

Agent Shelston IP

Pub. Number AU-A-2004249099

PCT Pub. Number WO2004/112784

Priority 0301882-7 25.06.03 SE

Filing date 21 June 2004

Wipo publication date 29 December 2004

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 17/02 (2006.01) Drugs for dermatological disorders

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/112784 Priority application(s): WO2004/112784

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249102-Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol

2004249092-Systems and procedures for treating cardiac arrest